Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible Staphylococcus aureus. Staphylococcus aureus is a leading cause of nosocomial and community acquired infections.

Testing market is projected to expand steadily over the next decade, rising from an estimated USD 4.3 billion in 2025 to USD ...

Without treatment, the infection can enter ... which is the incubation period for the infection. Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria highly resistant ...

A groundbreaking study has unveiled how Staphylococcus aureus, a bacterium often found in humans, evolves and survives, ...

MRSA - or methicillin resistant staphylococcus aureus - has already become resistant to most common antibiotics, making it difficult to treat with drugs. Once it gets into the body, through wounds ...

Alternative treatments may be costly and ... In 1962, the first case of methicillin-resistant Staphylococcus aureus (MRSA) was identified. Resistance of certain bacteria to other antibiotics was also ...

MRSA is a super bacteria that can cause serious infections which are resistant to antibiotic treatments ... MRSA bacteria (methicillin-resistant Staphylococcus aureus) is spread through person ...

Researchers have described how the bacterium Staphylococcus aureus genetically adapts to humans, including mutations that allow some strains to evade the immune system and become resistant to ...

Azithromycin is a versatile antibiotic used to treat a wide variety of bacterial infections, including those affecting the ...

P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

Pune: Doctors have reported a steady increase in infections resistant to antibiotics among children in the city, indicating that humans without the us.